Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.

Therapeutic area

Cardiovascular

How can we help?

16M+

patients with cardiovascular disease

4.6B+

clinical notes

10.8B+

lab results

3.4M+

echocardiogram reports with 69M+ echo-derived measurements

9M+

patients with implanted/explanted devices, including stents and valves

700K+

cardiac catheterization reports with 4.7M+ cath-derived measurements

Research cardiovascular disease with unmatched depth

Go beyond diagnoses and billing codes with clinically rich cardiovascular data, including:

Cardiac function and disease severity

  • Left ventricular ejection fraction (LVEF)
  • Tricuspid annular plane systolic excursion (TAPSE)
  • New York Heart Association (NYHA) functional class
  • Symptom burden and functional status, including New York Heart Association (NYHA) class
  • Cardiomyopathy subtypes and disease classification
  • Stenosis, occlusion, calcification, site, and vascular disease burden

Devices and procedure

  • Inpatient and outpatient interventions, including ablation and coronary revascularization procedures
  • Device type, manufacturer, and version
  • Procedural, and surgical logs with minute-level timestamps
  • Intraoperative, peri-procedural, and post-procedural complications

Social, behavioral, and familial risk factors

  • Social determinants of health (SDOH)
  • Behavioral and lifestyle factors
  • Family history and inherited cardiovascular risk

Cardiac function and disease severity

Devices and procedure

Social, behavioral, and familial risk factors

Structure, symptoms, and disease burden

Echocardiogram measurements, including Left ventricular ejection fraction (LVEF) and Tricuspid annular plane systolic excursion (TAPSE)
Symptom burden and functional status, including New York Heart Association (NYHA) class
Cardiomyopathy subtypes and disease classification
Stenosis, occlusion, calcification, site, and vascular disease burden

Interventions and outcomes

Inpatient and outpatient interventions, including ablation and coronary revascularization procedures
Device type, manufacturer, and version
Procedural, and surgical logs with minute-level timestamps
Intraoperative, peri-procedural, and post-procedural complications

Risk and patient background

Social determinants of health (SDOH)
Behavioral and lifestyle factors
Family history and inherited cardiovascular risk

Unlock novel variables from notes

Truveta brings extraordinary clinical depth to cardiovascular research, capturing regulatory-grade variables from clinical notes—including disease severity, cardiac function, device and procedural details, labs, and vitals.

Integrated with structured EHR data and timestamped to the minute, these research-ready variables enable the study of complex cardiovascular conditions with precision, including rare and low-prevalence diseases.

Identify patients with right ventricular dysfunction and pulmonary hypertension by extracting echocardiogram-derived measures (e.g., LVEF, chamber size, pressure estimates) and clinician interpretation—not just structured fields or procedure codes.

Visualize the complete patient journey

Connect rich clinical context with imaging and waveform data, searchable by modality and protocol—including DICOM images with pixel and metadata—across the complete patient journey. Enable deeper analysis of cardiac function, rhythm, procedures, and care events in a single, longitudinal view.

Echocardiogram studies and other imaging data and waveforms, such as ECGs, are available to evaluate disease progression, build AI models, and adjudicate outcomes

Echocardiograms
CT, MRI, and nuclear imaging findings
Radiology report data
Invasive hemodynamic and catheterization measurements
Coronary and structural lesion characterization

Echocardiogram studies and other imaging data and waveforms, such as ECGs, are available to evaluate disease progression, build AI models, and adjudicate outcomes

Accelerate insights to real-world impact

Discovery

Develop AI models using cardiovascular data (ECG, CT, and MRI) to detect disease patterns and progression

Clinical trials

Shorten development timelines by identifying eligible patients with cardiovascular disease faster with precise cohorts for site selection

Therapy adoption

Empower your field teams with more timely intelligence and differentiated evidence while tracking device utilization, revascularization strategies, and variation in care with daily updates

Safety

Detect cardiovascular complications and device risks earlier with longitudinal clinical and device data

Outcomes research

Replace costly phase IV trials with regulatory-grade confirmatory evidence and explore label expansion opportunities